March 4, 2026
SetupFree
MonthlyFree
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
This listing was created by AgentSquare from publicly available information.
What happens next: We'll share your details with the Vendor team and introduce you. No commitment.
Listed By
AgentSquare
This profile was created by AgentSquare based on publicly available information to help buyers discover AI agents. It is not managed by the vendor. Information may be incomplete.
Are you behind this agent?
Sign in to Claim